Trialbee Added AI Agent to Honey Platform
The new tool automates candidate pre-screening to address bottlenecks in clinical trial recruitment.
Updated on Sept. 27, 2026 in Artificial Intelligence
Live Poll
Do you trust artificial intelligence to handle your initial screening for medical research participation?
Trialbee has integrated an artificial intelligence pre-screening agent into its Honey Platform. The technology is designed to streamline clinical trial recruitment by allowing patients to complete secondary screenings immediately.
Why it matters
The technology addresses a persistent recruitment bottleneck where late-stage candidate disqualification slows down research progress. By automating the filtering process, the platform improves the efficiency of matching patients to studies.
The AI agent utilizes approved study content and defined protocol criteria to vet candidates. It provides answers regarding study locations and visit requirements while escalating complex inquiries that fall outside its scope to human staff.
The players
Trialbee
Headquartered in Wilmington, Delaware, this company provides technology solutions for patient recruitment in clinical trials.
Honey Platform
This is Trialbee's proprietary digital platform used to manage and optimize the patient enrollment process for clinical research.
The details
The platform allows patients to complete secondary screening within the digital interface or request a live call with a nurse. By applying configured protocol criteria to filter candidates before referral to research sites, the system ensures that only qualified individuals move forward in the process.
Timeline
Trialbee announced the integration of the AI pre-screening agent on September 27, 2026.
The Tech Race
The integration of AI into the Honey Platform follows a broader industry push to automate patient outreach and eligibility verification. This shift signals a move away from manual recruitment processes that have historically slowed medical research timelines.
Patients participating in research may experience faster response times and more immediate clarity regarding their eligibility for specific trials. By offering the option to speak with a nurse, the system maintains a human touch point for users who have concerns about study requirements.
The takeaway
Automating initial screenings reduces the administrative burden on research sites and helps patients get faster answers. This advancement underscores the growing role of AI in optimizing complex, data-heavy processes within the healthcare sector.
Further reading
For more on how new tools are changing the industry, see the latest developments in Artificial Intelligence.
Source note: This article includes information reported by MyChesCo.
Live Poll
Do you trust artificial intelligence to handle your initial screening for medical research participation?
